Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 68786-66-3
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of triclabendazole during breastfeeding. Because of protein binding of 96% to 99% for the drug and metabolites, exposure of the breastfed infant is likely to be low.
Drug Levels
Triclabendazole is metabolized into its active sulfoxide metabolite, which is further metabolized to the active sulfone metabolite. These drugs have half-lives of 8, 14, and 11 hours, respectively. Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Triclabendazole
CAS Registry Number
68786-66-3
Drug Class
- Breastfeeding
- Lactation
- Anti-Infective Agents
- Antiparasitic Agents
- Antiplatyhelmintic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Lofexidine.[Drugs and Lactation Database (...]Review Lofexidine.. Drugs and Lactation Database (LactMed®). 2006
- A molecular modeling approach to in vivo efficacy of triclabendazole.[J Parasitol. 1991]A molecular modeling approach to in vivo efficacy of triclabendazole.Lipkowitz KB, McCracken RO. J Parasitol. 1991 Dec; 77(6):998-1005.
- Uncoupling of rat liver mitochondrial oxidative phosphorylation by the fasciolicide triclabendazole and its sulfoxide and sulfone metabolites.[J Parasitol. 1993]Uncoupling of rat liver mitochondrial oxidative phosphorylation by the fasciolicide triclabendazole and its sulfoxide and sulfone metabolites.Carr AW, McCracken RO, Stillwell WH. J Parasitol. 1993 Apr; 79(2):198-204.
- Review Isoflurane.[Drugs and Lactation Database (...]Review Isoflurane.. Drugs and Lactation Database (LactMed®). 2006
- Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole.[Chem Pharm Bull (Tokyo). 2002]Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole.Hernández-Campos A, Ibarra-Velarde F, Vera-Montenegro Y, Rivera-Fernández N, Castillo R. Chem Pharm Bull (Tokyo). 2002 May; 50(5):649-52.
- Triclabendazole - Drugs and Lactation Database (LactMed®)Triclabendazole - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...